The mortality rate for humanity may indeed be 100%, but a new study suggests that CPAP therapy can help people who have both chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA). A wrapup in this week’s Medical Press calls the phenomenon “the overlap syndrome.”
This study adds to the growing body of literature regarding the combined impact of OSA in patients with COPD,” said lead author and principal investigator Michael L. Stanchina, MD, clinical assistant professor of medicine at the Alpert Medical School of Brown University and physician at Rhode Island Hospital in Providence, R.I. “We have shown that more time on CPAP in patients with the overlap syndrome was associated with a reduced risk of death, after controlling for common risk factors.”
The study “Impact of CPAP Use and Age on Mortality in Patients with Combined COPD and Obstructive Sleep Apnea: The Overlap Syndrome” published in the current issue of the Journal of Clinical Sleep Medicine, concerned a post hoc analysis of 10,272 outpatients. According to a Medical Press report, Stanchina’s team identified a study sample of 3,396 patients from 2007-2010 who had COPD or OSA.
This sample included 227 overlap syndrome patients who had both COPD and OSA. All patients in the overlap group were treated with CPAP therapy, and objective treatment compliance data were collected for the first one to three months of use. Seventeen patients with the overlap syndrome died.
Multivariate analysis revealed that hours of CPAP use at night is an independent predictora of mortality (hazard ratio = 0.71) in patients with COPD and OSA. Results show that overlap syndrome patients who use CPAP have a significantly higher survival than those who do not. Even minimal use of CPAP was associated with some reduction in the risk of death, and this benefit increased with more nightly hours of CPAP therapy.
“We were most surprised to find that any level of CPAP use in this cohort, over no use, was associated with some mortality benefit,” said Stanchina.